Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

5.700 -0.260 (-4.36%)
Official Closing Price Updated: 7:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
10 Stocks That Could Rise 10x (Safely)
There are two ways to find stocks that could rise 10x. Here are those strategies, and 10 stocks you can buy now to profit. 
Via InvestorPlace
AMTD Digital and MEGL Stock: Are Meme Stocks Back?
Meteoric rises in HKD stock and MEGL stock have led some to declare a resurgence in meme stocks. Here's how you can profit. 
Via InvestorPlace
ZYMERGEN ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ZY and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal
Via Benzinga
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock
Shares of DNA stock are in focus following Ark Invest's buying spree this month. In the past two days, Ark has purchased 4.5 million shares. 
Via InvestorPlace
Losing Money Is in Ginkgo Bioworks Holdings’ DNA
DNA stock is a falling knife in 2022, and the latest earnings do not justify being optimistic about reaching profitability soon. 
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sharps Compliance Corp. (Nasdaq - SMED), Infrastructure and Energy Alternatives, Inc. (Nasdaq - IEA), AutoWeb, Inc. (Nasdaq - AUTO), Zymergen Inc. (Nasdaq - ZY)
From Brodsky & Smith LLC
Via GlobeNewswire
Cathie Wood Loaded Up on Zymergen (ZY) Stock Before Ginkgo Buyout
Zymergen shares are rallying after an all-stock buyout from Ginkgo Bioworks. Cathie Wood's Ark owns both DNA shares and ZY stock. 
Via InvestorPlace
Zymergen (ZY) Stock Soars 20% on Acquisition News
Zymergen finally received some much-needed good news when Ginkgo Bioworks agreed to buy out the firm, sending ZY stock soaring. 
Via InvestorPlace
AAPL Stock: When Are Apple Earnings 2022?
Investors in Apple (AAPL) stock are anxiously waiting for the company's upcoming earnings report, which is set to take place on Thursday! 
Via InvestorPlace
Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today?
DNA stock is down even while Ginkgo Bioworks prepares to purchase a biotech business and a large research and development site. 
Via InvestorPlace
WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
  Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share... 
Via Benzinga
5 Top Stocks Cathie Wood Bought This Week
Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks. 
Via InvestorPlace
7 Stocks Under $10 That Can Double in One Year
These seven stocks under $10 have strong fundamentals and can bounce back by 100% from oversold levels in the next 12 months. 
Via InvestorPlace
5 Top Stocks Cathie Wood Bought This Week
Cathie Wood is still buying the dip and believes that deflationary forces may soon show out. Here are five top stocks she bought this week. 
Via InvestorPlace
Cathie Wood Just Doubled Down on Ginkgo Bioworks (DNA) Stock
While Ginkgo Bioworks may be a relatively unknown name to many investors, DNA stock is quite well known to Cathie Wood and her Ark funds. 
Via InvestorPlace
Futures, Yields, Oil And Gold Slide As German Confidence Plummets To 2011 Lows, Euro Hits Parity
US index futures, global markets, Treasury yields, bitcoin and oil all fell on Tuesday as the dollar continued its relentless ascent to levels just shy of the March 2020 global crash record high... 
Via Talk Markets
This Healthcare Stock is Surging By Over 21%: Here's 24 Biggest Movers In Tuesday's Pre-Market
Gainers Versus Systems Inc. (NASDAQ: VS) rose 66% to $0.7802 in pre-market trading. Versus Systems, last month, received NASDAQ notification regarding minimum bid price deficiency. 
Via Benzinga
7 Best Biotech Stocks to Buy in July 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. 
Via InvestorPlace
Billionaire Andreas Halvorsen Just Bought DNA Stock. Here’s Why.
DNA stock is surging higher today following large purchases from Viking Global's Andreas Halvorsen and Ark Invest's Cathie Wood. 
Via InvestorPlace
Beware These 7 Penny Stock Bubbles Getting Ready to Burst
The following penny stocks have built up a large bubble that is yet to burst. They are likely to burst soon due to the market decline. 
Via InvestorPlace
Is TSLA Stock Still a Buy? 5 Analysts Weigh In.
Tesla (TSLA) stock is a hot topic on Tuesday as analysts react to the company's EV deliveries for the second quarter of 2022. 
Via InvestorPlace
Cathie Wood Is Making a Big Bet on Gingko Bioworks (DNA) Stock
Cathie Wood's Ark Invest has purchased more than 3.5 million shares of DNA stock since June 29, its first purchases in over a month. 
Via InvestorPlace
Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity... 
Via Benzinga
Cronos Group And Ginkgo Bioworks Achieve Rare Cannabinoid THCV Equity Milestone
Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) and Ginkgo Bioworks (NYSE: DNA) achieved the third target productivity milestone in their partnership 
Via Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves? 
Via InvestorPlace
74 Biggest Movers From Yesterday
Gainers 
Via Benzinga
ADSK Stock Sinks 8% Following Analyst Downgrade
Autodesk (ADSK) stock is slipping on Monday after getting hit with a downgrade and price target drop from Deutsche Bank analyst Bhavin Shah. 
Via InvestorPlace
Benzinga Bulls And Bears Of The Week: Netflix, Coinbase, Apple, Rivian And A Biotech Scooped Up By Cathie Wood
Benzinga has examined the prospects for many investor favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.